Backed by 20 years of experience in the pharmaceutical sector, I provide freelance and contract writing editing, fact-checking and proofreading services to healthcare agencies, pharmaceutical companies, institutions and CROs around Australia, ensuring their digital content and printed materials are accurate, scientifically robust and highly readable.Organisations I have worked with include: Paper+Spark, Ubiquity Lab, Co-Med, AME Publishing Company, The Native Content Company, Splice Marketing, Arterial Group, Oasis Partners.

I'm a contributing editor, conducting fact-checking, editing and proofreading articles for digital publication on the ScienceAlert website. Categories include medical health, nature, environment, physics, technology, society and space.

I designed, edited and produced 7 issues of Women’s Ink! magazine, the official publication of The Society of Women Writers NSW, creating a contemporary and accessible publication that proudly showcases members' voices. The magazine is issued 3 times a year.I was independently responsible for producing the magazine, I also commissioned articles, conducted interviews with industry professionals, and develop regular sections, which dramatically increased member engagement and contributions.‘[Jacqui’s] skill at editing articles and passion to increase the relevance of 'Ink!' has been significant in moving the magazine into today. I strongly recommend her.’ Susanne Gervay, OAM

Managing the medical and scientific information for the Australia and New Zealand Affiliate, including:MEDICAL INFORMATION: Researching, writing and communicating clear, accurate and up-to-date medical and technical information to consumers, healthcare professionals and internal staff, in audience-appropriate language and formats. Handling incoming product enquiries and complaints. STAFF TRAINING: Structuring, writing and developing training materials. Delivering onboarding and ongoing training to internal staff in products. Localising and editing international product materials for the Australian and New Zealand markets.PROMOTIONAL REVIEW: Supporting marketing with scientific input into materials and events. Responsible for copy approval of corporate, educational and marketing materials to ensure scientific accuracy and compliance with all regulatory requirements and relevant codes of conductPHARMACOVIGILANCE: Timely and accurate identification, reporting, follow up and reconciliation of adverse event reports, including reporting to the TGA.Management of INVESTIGATOR INITIATED STUDIES: MOVICOL, NORMAFIBE and NORMACOL Plus (unscheduled) MOVIPREP and PLENVU (S3), MUCOGARD and XIFAXIN 200 (S4), XIFAXIN 550 (S4 specialist medication) and ENDOCUFF Vision (specialist device).

Project management of Phase I to Phase III clinical trials, across numerous therapeutic areas, within Australia for external and international clients. Ensuring delivery of quality data, on time and on budget, whilst maintaining compliance with protocol, company and client standard operating procedures, industry standards and regulatory requirements for the project.

Set up and manage execution of Phase III clinical trials, across numerous therapeutic areas, within Australia for external clients. Ensure delivery of quality data, on time and on budget, whilst maintaining compliance with protocol, company and client standard operating procedures, industry standards and regulatory requirements for the project.

Specialty area: Multiple Sclerosis

Therapeutic areas: Gastroenterology and Respiratory

Therapeutic areas: Neurology, Cardiology and Erectile Dysfunction